Literature DB >> 2529926

Inversion of chromosome 7 in ataxia telangiectasia is generated by a rearrangement between T-cell receptor beta and T-cell receptor gamma genes.

M H Stern1, S Lipkowitz, A Aurias, C Griscelli, G Thomas, I R Kirsch.   

Abstract

Specific and recurrent chromosomal rearrangements are often observed in the karyotypes of phytohemagglutinin-stimulated lymphocytes. The percentage of cells demonstrating these rearrangements is dramatically increased in the genetic disease ataxia telangiectasia. Inversion of chromosome 7 represents approximately half of the chromosomal rearrangements in this disease. Because the chromosomal locations of the inv(7) breakpoints coincide precisely with those of the T-cell antigen receptor (TCR) beta and gamma genes, it has been hypothesized that this rearrangement may occur by recombination between those two loci. Here, we present direct evidence that inversion of chromosome 7 in ataxia telangiectasia is generated by site-specific recombination between a TCR gamma variable segment and a TCR beta joining segment.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2529926

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  11 in total

Review 1.  The molecular biology of B-cell lymphoma: clinicopathologic implications.

Authors:  P M Kluin; J H van Krieken
Journal:  Ann Hematol       Date:  1991-04       Impact factor: 3.673

2.  Comprehensive translocation and clonality detection in lymphoproliferative disorders by next-generation sequencing.

Authors:  Dörte Wren; Brian A Walker; Monika Brüggemann; Mark A Catherwood; Christiane Pott; Kostas Stamatopoulos; Anton W Langerak; David Gonzalez
Journal:  Haematologica       Date:  2016-10-20       Impact factor: 9.941

3.  A hypomorphic Artemis human disease allele causes aberrant chromosomal rearrangements and tumorigenesis.

Authors:  Cheryl Jacobs; Ying Huang; Tehmina Masud; William Lu; Gerwin Westfield; William Giblin; JoAnn M Sekiguchi
Journal:  Hum Mol Genet       Date:  2010-12-08       Impact factor: 6.150

4.  Interlocus V-J recombination measures genomic instability in agriculture workers at risk for lymphoid malignancies.

Authors:  S Lipkowitz; V F Garry; I R Kirsch
Journal:  Proc Natl Acad Sci U S A       Date:  1992-06-15       Impact factor: 11.205

5.  Cytogenetic investigations in three cell types of a Saudi family with ataxia telangiectasia.

Authors:  M Waghray; G G Gascon; S al-Sedairy; M A Hannan
Journal:  Hum Genet       Date:  1991-07       Impact factor: 4.132

6.  Leaky severe combined immunodeficiency and aberrant DNA rearrangements due to a hypomorphic RAG1 mutation.

Authors:  William Giblin; Monalisa Chatterji; Gerwin Westfield; Tehmina Masud; Brian Theisen; Hwei-Ling Cheng; Jeffrey DeVido; Frederick W Alt; David O Ferguson; David G Schatz; JoAnn Sekiguchi
Journal:  Blood       Date:  2009-01-06       Impact factor: 22.113

7.  A novel T cell subset with trans-rearranged Vγ-Cβ TCRs shows Vβ expression is dispensable for lineage choice and MHC restriction.

Authors:  Steven Bowen; Peter Sun; Ferenc Livak; Susan Sharrow; Richard J Hodes
Journal:  J Immunol       Date:  2013-12-04       Impact factor: 5.422

8.  Hybrid T cell receptor genes formed by interlocus recombination in normal and ataxia-telangiectasis lymphocytes.

Authors:  S Lipkowitz; M H Stern; I R Kirsch
Journal:  J Exp Med       Date:  1990-08-01       Impact factor: 14.307

9.  Concurrent V(D)J recombination and DNA end instability increase interchromosomal trans-rearrangements in ATM-deficient thymocytes.

Authors:  Steven Bowen; Darawalee Wangsa; Thomas Ried; Ferenc Livak; Richard J Hodes
Journal:  Nucleic Acids Res       Date:  2013-03-06       Impact factor: 16.971

10.  Surface expression of functional T cell receptor chains formed by interlocus recombination on human T lymphocytes.

Authors:  F Davodeau; M A Peyrat; J Gaschet; M M Hallet; F Triebel; H Vié; D Kabelitz; M Bonneville
Journal:  J Exp Med       Date:  1994-11-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.